-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Impact Biomedical Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2022 to 2023.
- Impact Biomedical Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$712K, a 29.8% increase year-over-year.
- Impact Biomedical Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$2.85M, a 27.2% decline from 2022.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)